Logo image of SNES

SENESTECH INC (SNES) Stock Price, Quote, News and Overview

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD

3.0283  -0.29 (-8.79%)

After market: 3.15 +0.12 (+4.02%)

SNES Quote, Performance and Key Statistics

SENESTECH INC

NASDAQ:SNES (2/21/2025, 8:00:02 PM)

After market: 3.15 +0.12 (+4.02%)

3.0283

-0.29 (-8.79%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High9.8
52 Week Low1.9
Market Cap3.12M
Shares1.03M
Float1.03M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-07 2025-05-07
IPO12-08 2016-12-08


SNES short term performance overview.The bars show the price performance of SNES in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20 30

SNES long term performance overview.The bars show the price performance of SNES in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SNES is 3.0283 USD. In the past month the price decreased by -1.04%. In the past year, price decreased by -65.87%.

SENESTECH INC / SNES Daily stock chart

SNES Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.53 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.62 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.81 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About SNES

Company Profile

SNES logo image Senestech Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Phoenix, Arizona and currently employs 25 full-time employees. The company went IPO on 2016-12-08. SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The firm has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The firm's technology can also be applied to other mammalian species.

Company Info

SENESTECH INC

777 W. Pinnacle Peak Road, Suite B104

Phoenix ARIZONA 85027 US

CEO: Kenneth Siegel

Employees: 25

Company Website: https://senestech.com/

Investor Relations: https://senestech.investorroom.com/

Phone: 19287794143

SENESTECH INC / SNES FAQ

What is the stock price of SENESTECH INC today?

The current stock price of SNES is 3.0283 USD. The price decreased by -8.79% in the last trading session.


What is the ticker symbol for SENESTECH INC stock?

The exchange symbol of SENESTECH INC is SNES and it is listed on the Nasdaq exchange.


On which exchange is SNES stock listed?

SNES stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SENESTECH INC stock?

7 analysts have analysed SNES and the average price target is 10.2 USD. This implies a price increase of 236.82% is expected in the next year compared to the current price of 3.0283. Check the SENESTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SENESTECH INC worth?

SENESTECH INC (SNES) has a market capitalization of 3.12M USD. This makes SNES a Nano Cap stock.


How many employees does SENESTECH INC have?

SENESTECH INC (SNES) currently has 25 employees.


What are the support and resistance levels for SENESTECH INC (SNES) stock?

SENESTECH INC (SNES) has a support level at 2.96 and a resistance level at 3.1. Check the full technical report for a detailed analysis of SNES support and resistance levels.


Is SENESTECH INC (SNES) expected to grow?

The Revenue of SENESTECH INC (SNES) is expected to grow by 61.35% in the next year. Check the estimates tab for more information on the SNES EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SENESTECH INC (SNES) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SENESTECH INC (SNES) stock pay dividends?

SNES does not pay a dividend.


When does SENESTECH INC (SNES) report earnings?

SENESTECH INC (SNES) will report earnings on 2025-05-07.


What is the Price/Earnings (PE) ratio of SENESTECH INC (SNES)?

SENESTECH INC (SNES) does not have a PE ratio as the earnings reported over the last twelve months were negative (-17.78).


What is the Short Interest ratio of SENESTECH INC (SNES) stock?

The outstanding short interest for SENESTECH INC (SNES) is 3.81% of its float. Check the ownership tab for more information on the SNES short interest.


SNES Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to SNES. When comparing the yearly performance of all stocks, SNES is a bad performer in the overall market: 82.89% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SNES Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SNES. Both the profitability and financial health of SNES have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNES Financial Highlights

Over the last trailing twelve months SNES reported a non-GAAP Earnings per Share(EPS) of -17.78. The EPS increased by 84.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -149.74%
ROE -182.47%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%96.33%
Sales Q2Q%33.89%
EPS 1Y (TTM)84.67%
Revenue 1Y (TTM)37.58%

SNES Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to SNES. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 96.61% and a revenue growth 61.35% for SNES


Ownership
Inst Owners2.2%
Ins Owners0.02%
Short Float %3.81%
Short Ratio0.22
Analysts
Analysts82.86
Price Target10.2 (236.82%)
EPS Next Y96.61%
Revenue Next Year61.35%